Toujeo
by Sanofi
Toujeo (insulin glargine) is a long-acting form of insulin used to lower glucose or blood sugar levels in adults with type 1 or type 2 diabetes. It is not yet approved for use by children. As a long-a...
Toujeo (insulin glargine) is a long-acting form of insulin used to lower glucose or blood sugar levels in adults with type 1 or type 2 diabetes. It is not yet approved for use by children. As a long-acting insulin, Toujeo works steadily over a 24-hour period. It must not be used during an episode of ketoacidosis or hypoglycemia.
Toujeo is available in two disposable, pre-filled pen injector versions: Toujeo Max SoloStar and Toujeo SoloStar. This allows for flexibility should insulin dosage needs change over time.
The Toujeo Max SoloStar injector contains 900 units delivered in 2-unit increments with a maximum dose of 160 units. Toujeo SoloStar contains 450 units delivered in 1-unit increments with a maximum dose of 80 units. Trujeo also boasts the lowest injection volume compared to other long-acting insulins currently on the market.
Patient assistance programs
Toujeo Patient Assistance Program
Manufacturer PAP- Eligibility
- Patients who meet income and insurance requirements
- Income limit
- Varies — contact ClariMeds for current limits
- Insurance
- Typically uninsured or underinsured; Medicare/Medicaid restrictions may apply
- How to apply
- Apply through ClariMeds — we handle the paperwork at no cost
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free